Enara Bio’s Dark Antigen presentations from the 37th Society for Immunotherapy of Cancer Annual Meeting
A team from Enara Bio, led by Vice President and Head of Research, Dr. Joe Dukes, and Head of TCR Pipeline and Dark Antigen Research, Dr. Rachel Abbott, presented two posters at the 37th Society for Immunotherapy of Cancer Annual Meeting, in Boston, MA., highlighting Dark Antigens as novel immunotherapy targets across solid tumors.
Abstract #312
Abstract #343
